Business Update
Company reports implant of Xelos DR-T implantable cardioverter defibrillator
Published in Medical Letter on the CDC and FDA, June 19th, 2005
The device is part of a state-of-the-art system that incorporates home monitoring early detection technology, biphasic II shock capability, and 36-Joule shock energy.
"The FDA approval of our Xelos DR-T high-energy ICD represents another milestone in our drive to deliver complete tachycardia solutions to our customers," said Jake Langer, president of BIOTRONIK, Inc. "The combination of our exclusive home monitoring technology and 36-Joule shock capability will further...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- Buruli Ulcer Disease
Risk factors for Buruli ulcer disease outlined - Cancer Pathogenesis
Liver sensitivity to nitrosourea mutagenicity is age dependent - Liver Cancer
Hepatitis B infections in hepatitis C-associated liver cancer examined - Pregnancy
Homicide is leading cause of injury deaths among pregnant women in U.S. - Stroke
Greater prevention efforts needed, especially in African Americans - Alcohol Use
Health behaviors help physicians identify women more likely to have been abused - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
